Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-16-466189
Filing Date
2016-02-17
Accepted
2016-02-17 06:15:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d135129dsc13g.htm SC 13G 35635
  Complete submission text file 0001193125-16-466189.txt   37459
Mailing Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filed by) CIK: 0000850261 (see all company filings)

EIN.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (858) 633-0300
NantKwest, Inc. (Subject) CIK: 0001326110 (see all company filings)

EIN.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88987 | Film No.: 161431556
SIC: 2836 Biological Products, (No Diagnostic Substances)